Testing effectiveness (Phase 2)Study completedNCT04269213
What this trial is testing
CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old
Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia With Myelodysplasia-Related ChangesSecondary Acute Myeloid Leukemia+1 more
Roswell Park Cancer Institute 21